
Novartis AG
NVSEF | OTC
$138.10
-$0.28 (-0.20%)
Sep 24, 2026, 10:16 AM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 11.46B | 13.39B | 7.52B | 12.41B | 9.66B | 11.11B |
Short-Term Investments | 1.89B | 680M | 11.41B | 15.92B | 1.91B | 334M |
Long-Term Investments | 1.13B | 1.83B | 2.55B | 3.24B | 12.53B | 11.16B |
Other Long-Term Assets | 4.53B | 11.82B | 1.11B | 2.21B | 892M | 738M |
Receivables | 9.54B | 8.12B | 8.94B | 8.82B | 9.07B | 9.17B |
Inventory | 5.71B | 5.91B | 7.18B | 6.67B | 7.13B | 5.98B |
Other Current Assets | 118.28M | 1.25B | 2.03B | 1.72B | 1.98B | 2.98B |
Total Current Assets | 29.7B | 30.48B | 36.91B | 45.72B | 29.67B | 29.5B |
Property-Plant & Equipment | 10.85B | 10.92B | 12.2B | 13.11B | 13.94B | 13.75B |
Goodwill & Intangibles | 51.67B | 44.89B | 60.95B | 63.78B | 66.81B | 55.31B |
Total Long-Term Assets | 72.54B | 69.46B | 80.54B | 86.08B | 102.39B | 88.87B |
Total Assets | 102.25B | 99.95B | 117.45B | 131.8B | 132.06B | 118.37B |
Account Payables | 4.57B | 4.93B | 5.15B | 5.55B | 5.4B | 5.42B |
Deferred Revenue | 127M | 98M | 123M | 123M | 56M | 114M |
Short-Term Debt | 8.09B | 6.08B | 5.93B | 6.3B | 9.79B | 7.03B |
Other Current Liabilities | 10.4B | 9.88B | 11.94B | 12.94B | 12.79B | 10.79B |
Total Current Liabilities | 28.69B | 26.39B | 28.66B | 30.21B | 33.06B | 28.26B |
Long-Term Debt | 21.37B | 18.44B | 20.24B | 22.9B | 26.26B | 20.35B |
Other Long-Term Liabilities | 4.08B | 4.52B | 4.91B | 4.55B | 8.82B | 7.08B |
Total Long-Term Liabilities | 29.43B | 26.81B | 29.37B | 33.77B | 42.33B | 34.56B |
Total Liabilities | 58.12B | 53.2B | 58.03B | 63.97B | 75.39B | 62.82B |
Total Debt | 31.26B | 26.35B | 27.96B | 31.09B | 38.05B | 29.33B |
Book Value | 44.13B | 46.75B | 59.42B | 67.82B | 56.67B | 55.55B |
Book Value Per Share | 21.68 | 22.35 | 27.05 | 30.01 | 24.68 | 23.95 |
Common Stock | 791.3M | 825M | 890M | 901M | 913M | 936M |
Retained Earnings | 46.46B | 49.63B | 63.57B | 70.9B | 57.16B | 59.28B |
Comprehensive Income | -3.26B | -3.76B | 58.54B | 66.8B | 55.74B | 54.62B |
Shareholders Equity | 44.05B | 46.67B | 59.34B | 67.66B | 56.6B | 55.47B |
Total Investments | 3.02B | 2.4B | 13.97B | 19.16B | 14.44B | 11.5B |
Add to Watchlist
Select watchlists to add or remove NVSEF